Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79464 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ranolazine Related Compound B (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H31N3O3Couleur et forme :White PowderMasse moléculaire :397.23654Deferasirox Related Compound F (4-Hydrazinylbenzoic acid)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C7H8N2O2Couleur et forme :Yellow Orange Brown PowderMasse moléculaire :152.05858Lumefantrine Related Compound A ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol hydrochloride)
Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C30H32Cl3NO·HClCouleur et forme :Yellow PowderMasse moléculaire :527.15495Methyldopa Related Compound B ((S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C11H15NO3·HClCouleur et forme :Grey PowderMasse moléculaire :245.08187Dopamine Related Compound C (2-(3,4-Dimethoxyphenyl)ethan-1-amine)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C10H15NO2Couleur et forme :Yellow Brown LiquidMasse moléculaire :181.23Eletriptan S-Enantiomer ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide)
Analgesics, antipyretics and non-hormonal anti-inflammatory agentsFormule :C22H26N2O2S·HBrCouleur et forme :Light Yellow PowderMasse moléculaire :462.09766Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C20H21F2N3O3Couleur et forme :White Off-White PowderMasse moléculaire :389.1551Methimazole Related Compound A (2,2-Dimethoxy-N-methylethanamine)
CAS :Amino-alcohols, other than those containing more than oneFormule :C5H13NO2Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :119.09463Nitazoxanide Related Compound B (2-Hydroxy-N-(5-nitrothiazol-2-yl) benzamide)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C10H7N3O4SCouleur et forme :Pale Yellow PowderMasse moléculaire :265.01573Ticagrelor Related Compound A ((1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine (R)-mandelate)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C9H9F2N·C8H8O3Couleur et forme :White Yellow SolidMasse moléculaire :321.11765Transplatin
CAS :Inorganic or organic compounds of precious metals, whether or not chemically defined, or amalgams of precious metals, nesoiFormule :Cl2H6N2PtCouleur et forme :Light Yellow PowderMasse moléculaire :300.05Travoprost Related Compound A ((Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-{(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl)hept-5-enoic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their deFormule :C23H29F3O6Couleur et forme :Colorless LiquidMasse moléculaire :458.19162Daunorubicinone ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione)
CAS :Ketone-phenols and ketones with other oxygen functionFormule :C21H18O8Couleur et forme :Orange Red PowderMasse moléculaire :398.10017R-Methotrexate (Sodium (R)-2-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C20H20N8Na2O5Couleur et forme :Yellow Dark Yellow PowderMasse moléculaire :498.1352Lindane Related Compound A ((1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-Hexachlorocyclohexane)
CAS :1,2,3,4,5,6-hexachlorocyclohexaneFormule :C6H6Cl6Couleur et forme :Off-White PowderMasse moléculaire :287.86007Verteporfin Related Compound A ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C40H40N4O8Couleur et forme :Dark Green PowderMasse moléculaire :704.77Ticlopidine Related Compound A (4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C7H7NOSCouleur et forme :White Off-White PowderMasse moléculaire :153.02484Tranylcypromine Related Compound A ((+/-)-cis-2-Phenylcyclopropanamine hydrochloride; cis-tranylcypromine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C9H11N·HClCouleur et forme :White PowderMasse moléculaire :133.08915Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Orphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride)
CAS :Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormule :C17H21NO·ClHCouleur et forme :White Off-White PowderMasse moléculaire :291.13899Flunixin Related Compound B (2-Methyl-3-(trifluoromethyl)aniline)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C8H8F3NCouleur et forme :White Off-White PowderMasse moléculaire :175.06088Atenolol Related Compound A (2-(4-Hydroxyphenyl)acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C8H9NO2Couleur et forme :Light Cream PowderMasse moléculaire :151.06333Nebivolol Related Compound D ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman)
CAS :Aromatic pesticides with oxygen heteroFormule :C11H11FO2Couleur et forme :Liquid Low-Melting SolidMasse moléculaire :194.07431Acetylcysteine Related Compound D (N,S-Diacetyl-L-Cysteine)
CAS :Other organo-sulfur acid compoundsFormule :C7H11NO4SCouleur et forme :White SolidMasse moléculaire :205.04088Nicotine Related Compound E ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C10H14N2OCouleur et forme :White Off-White PowderMasse moléculaire :178.11061Memantine Related Compound A (1,3-Dimethyladamantane)
CAS :Cyclanes, cyclenes and cycloterpenes, excluding cyclohexaneFormule :C12H20Couleur et forme :Clear Colorless LiquidMasse moléculaire :164.1565[D-His1]-Exenatide
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C184H282N50O60SCouleur et forme :White CrystalsMasse moléculaire :4184.02731Uracil
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C4H4N2O2Couleur et forme :White Off-White PowderMasse moléculaire :112.02728Leflunomide
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White PowderMasse moléculaire :270.06161Clomipramine Related Compound F (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine)
CAS :Aromatic or modified aromatic drugs with nitrogen heteroFormule :C14H12ClNCouleur et forme :Off-White SolidMasse moléculaire :229.06583Gadoteridol Related Compound C (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C14H24N4O5Couleur et forme :White Light Yellow PowderMasse moléculaire :328.17467Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H21N3O5Couleur et forme :White Off-White SolidMasse moléculaire :395.14812Pramipexole Related Compound G ((6S,7S)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
CAS :Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormule :C10H17N3OSCouleur et forme :Off-White SolidMasse moléculaire :227.10923Celecoxib Related Compound C (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C18H16F3N3O2SCouleur et forme :SolidMasse moléculaire :395.4Granisetron Related Compound C (N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H22N4O·HClCouleur et forme :White PowderMasse moléculaire :298.17936Phentermine Related Compound A (N-(2-Methyl-1-phenylpropan-2-yl)formamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H15NOCouleur et forme :White Off-White PowderMasse moléculaire :177.11536Decitabine Related Compound E (4-Amino-1-(2-deoxy-α-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C8H12N4O4Couleur et forme :White PowderMasse moléculaire :228.08585Azelastine Related Compound D (4-(4-chlorobenzyl)phthalazin-1(2H)-one)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H11ClN2OCouleur et forme :White PowderMasse moléculaire :270.05599Inamrinone Related Compound B (2-Hydroxy-N-(6-oxo-1,6-dihydro-[3,4'-bipyridin]-5-yl)propanamide)
Lactams not elsewhere specified or includedFormule :C13H13N3O3Couleur et forme :Tan PowderMasse moléculaire :259.09569Mirtazapine Related Compound D (2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C17H17N3OCouleur et forme :White Pale Yellow SolidMasse moléculaire :279.13716Metaxalone Related Compound B (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C11H17NO2Couleur et forme :White PowderMasse moléculaire :195.26Mefloquine Related Compound A (threo-mefloquine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H16F6N2O·HClCouleur et forme :White PowderMasse moléculaire :378.11668Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C17H19N3O·H2OCouleur et forme :Off-White White PowderMasse moléculaire :281.15281Phenylephrine Related Compound E (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C16H17NO2·HClCouleur et forme :Grey To White PowderMasse moléculaire :291.10261Brimonidine Related Compound A (5-Bromoquinoxalin-6-amine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C8H6BrN3Couleur et forme :Yellow Crystalline PowderMasse moléculaire :222.97451Pioglitazone Hydrochloride
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C19H20N2O3S·HClCouleur et forme :White PowderMasse moléculaire :356.11946Gabapentin Related Compound D ([1-(3-Oxo-2-aza-spiro[4.5]dec-2-ylmethyl)cyclohexyl]acetic acid)
CAS :Lactams not elsewhere specified or includedFormule :C18H29NO3Couleur et forme :White PowderMasse moléculaire :307.21474Bisacodyl Related Compound E (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C22H19NO4Couleur et forme :White Off-White PowderMasse moléculaire :361.13141Nicotine Related Compound A (1,2,3,6-tetrahydro-2,3'-bipyridine)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C10H12N2Couleur et forme :Pale Yellow Light Brown LiquidMasse moléculaire :160.22Tizanidine Related Compound A (4-amino-5-chloro-2,1,3-benzothiadiazole)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C6H4ClN3SCouleur et forme :Orange PowderMasse moléculaire :184.98145Ropinirole Related Compound A (4-(2-hydroxyethyl)indolin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C10H11NO2Couleur et forme :Light Yellow PowderMasse moléculaire :177.07898Cefadroxil Related Compound I ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS :Aminoglycoside antibioticsFormule :C16H17N3O5SCouleur et forme :Off-White PowderMasse moléculaire :363.08889Cefprozil (Z)-Isomer
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19N3O5S·H2OCouleur et forme :PowderMasse moléculaire :389.10454Orlistat Related Compound C (Triphenylphosphine Oxide)
CAS :Non-halogenated organo-phosphorous derivatives, nesoiFormule :C18H15OPCouleur et forme :White Beige PowderMasse moléculaire :278.08605Chlorobenzhydryl Piperazine
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C17H19ClN2Couleur et forme :White Off-White PowderMasse moléculaire :286.12368Carprofen Related Compound A (Carbazole)
CAS :CarbazoleFormule :C12H9NCouleur et forme :Beige PowderMasse moléculaire :167.0735Amantadine Related Compound B (N-(Adamantan-1-yl)acetamide)
CAS :Cyclic amides and their derivatives, nesoiFormule :C12H19NOCouleur et forme :White PowderMasse moléculaire :193.14666Nifedipine Nitrophenylpyridine Analog (Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H16N2O6Couleur et forme :White Yellow PowderMasse moléculaire :344.33Triprolidine Hydrochloride Z-Isomer
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C19H22N2·HClCouleur et forme :White Crystalline PowderMasse moléculaire :278.1783Levofloxacin Related Compound E ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H18FN3O4·HClCouleur et forme :Off-White Yellow PowderMasse moléculaire :371.10481Amantadine Related Compound A (1-Chloroadamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C10H15ClCouleur et forme :White CrystalsMasse moléculaire :170.08623Triclocarban Related Compound A (1,3-Bis(4-chlorophenyl)urea)
CAS :Ureines and their derivatives; salts thereofFormule :C13H10Cl2N2OCouleur et forme :White Off-White PowderMasse moléculaire :280.01702Terbinafine Related Compound A (N-methyl-C-(naphthalen-1-yl)methanamine hydrochloride)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C12H14ClNCouleur et forme :White PowderMasse moléculaire :207.08148Zonisamide Related Compound C (N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide)
CAS :Sulfonamides, nesoiFormule :C11H13N3O3SCouleur et forme :White SolidMasse moléculaire :267.06776Sevoflurane Related Compound C (1,1,1,3,3,3-hexafluoro-2-propanol)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatives of acyclic alcohols, nesoi (excluding ethchlorovynol [inn])Formule :C3H2F6OCouleur et forme :Clear Colorless LiquidMasse moléculaire :168.00098Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS :Lactams, nesoiFormule :C26H25N5O5Couleur et forme :White Off-White PowderMasse moléculaire :487.18557Bimatoprost Related Compound A ((E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C25H37NO4Couleur et forme :LiquidMasse moléculaire :415.27226Brinzolamide Related Compound A ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer))
CAS :Sulfonamides, nesoiFormule :C12H21N3O5S3Couleur et forme :White Off-White PowderMasse moléculaire :383.06433Anagrelide Related Compound C (Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate)
CAS :Drugs containing a pyrimidine ring (whether or not hydrFormule :C12H13Cl2N3O2·HBrCouleur et forme :Light Yellow PowderMasse moléculaire :301.03848Xanthanoic Acid
CAS :Aromatic heterocyclic pesticides with oxygen hetero-atom(s) only, nesoiFormule :C14H10O3Couleur et forme :White PowderMasse moléculaire :226.23Famciclovir Related Compound E (2-aminopurine)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C5H5N5Couleur et forme :PowderMasse moléculaire :135.0545Acetaldehyde
CAS :Ethanal (acetaldehyde)Formule :C2H4OCouleur et forme :Clear Colorless LiquidMasse moléculaire :44.02621Granisetron Related Compound B (N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H22N4OCouleur et forme :Off-White White PowderMasse moléculaire :298.17936Desogestrel Related Compound A (13-Ethyl-11-methylene-18,19-dinor-5α,17α-pregn-3-en-20-yn-17-ol)
CAS :Sterols and inositolsFormule :C22H30OCouleur et forme :White PowderMasse moléculaire :310.22967Ibuprofen Related Compound J (2-(4-Isobutyrylphenyl)propanoic acid)
CAS :Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc not elsewhere specified or includedFormule :C13H16O3Couleur et forme :Brown SolidMasse moléculaire :220.10994Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H26ClN3O8SCouleur et forme :White Off-White SolidMasse moléculaire :611.11291Temozolomide Related Compound A (4-diazo-4H-imidazole-5-carboxamide)
CAS :Compounds containing an unfused imidazole ring (whetherFormule :C4H3N5OCouleur et forme :PowderMasse moléculaire :137.03376Selegiline Related Compound D ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C12H15N·HClCouleur et forme :White Off-White PowderMasse moléculaire :209.09713Letrozole Related Compound A (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H11N5Couleur et forme :White Off-White PowderMasse moléculaire :285.10145Levofloxacin Related Compound A ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H18FN3O4Couleur et forme :White PowderMasse moléculaire :347.34Diclofenac Potassium
CAS :Aromatic amino-acids and their esters,other than those containing more than one kind of oxygen function for use as drugsFormule :C14H10Cl2KNO2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :332.97257Vigabatrin Related Compound A (5-vinylpyrrolidin-2-one)
CAS :Amino-acids (excluding aromatic) and their esters other than those containing more than one kind of oxygen function, nesoiFormule :C6H9NOCouleur et forme :Clear Colorless Reddish-Brown LiquidMasse moléculaire :111.06841Acitretin Related Compound A ((2Z,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C21H26O3Couleur et forme :Yellow Crystalline PowderMasse moléculaire :326.44Norfloxacin Related Compound K (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C15H16FN3O3Couleur et forme :Off-White SolidMasse moléculaire :305.11757Terbinafine Related Compound B ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)
CAS :Aromatic monoamines not elsewhere specified or includedFormule :C21H25N·HClCouleur et forme :Off-White PowderMasse moléculaire :291.1987Sodium Picosulfate Related Compound A (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H14NNaO5SCouleur et forme :White PowderMasse moléculaire :379.04904Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS :Nitrile function compounds, not elsewhere specified or includedFormule :C12H9F3N2O2Couleur et forme :White Off-White PowderMasse moléculaire :270.06161Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H12N2O2Couleur et forme :White PowderMasse moléculaire :216.08988Acetaminophen Related Compound B (N-(4-hydroxyphenyl)propanamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C9H11NO2Couleur et forme :White Brown PowderMasse moléculaire :165.07898Valsartan Related Compound A (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}D-valine)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C24H29N5O3Couleur et forme :Off-White PowderMasse moléculaire :435.22704Moxifloxacin Related Compound F (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C22H26FN3O4Couleur et forme :Off-White Yellow Tan PowderMasse moléculaire :415.19073Telmisartan Related Compound A (1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole monohydrate)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C19H20N4·H2OCouleur et forme :Off-White SolidMasse moléculaire :322.17936Bisacodyl Related Compound A (4,4'-(Pyridin-2-ylmethylene)diphenol)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H15NO2Couleur et forme :White Crystalline PowderMasse moléculaire :277.11028Famotidine Related Compound B (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H23N11O2S5Couleur et forme :Yellow White PowderMasse moléculaire :561.06397Spironolactone Related Compound D ((2'R)-7α-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C24H32O4S2Couleur et forme :White PowderMasse moléculaire :448.1742Rivastigmine Tartrate R-Isomer ((R)-3-[1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate, hydrogen tartrate)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H22N2O2·C4H6O6Couleur et forme :White PowderMasse moléculaire :250.16813Buspirone Related Compound G (1,4-Di(pyrimidin-2-yl)piperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C12H14N6Couleur et forme :Pale Yellow Off-White PowderMasse moléculaire :242.12799Rivastigmine Related Compound E ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C15H25ClN2O2Couleur et forme :White SolidMasse moléculaire :300.16046Aminocaproic Acid Related Compound B (6-[6-(6-Aminohexanamido)hexanamido]hexanoic acid)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C18H35N3O4Couleur et forme :White SolidMasse moléculaire :357.26276Rivaroxaban Ethylamino Analog (1-amino-3-((4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20ClN3O4S·2HClCouleur et forme :White Off-White SolidMasse moléculaire :409.0863o-Flutamide
Aromatic cyclic amides (including cyclic carbamates) anFormule :C11H11F3N2O3Couleur et forme :PowderMasse moléculaire :276.22Potassium Ferrocyanide
CAS :Complex cyanidesFormule :K4Fe(CN)6·3H2OCouleur et forme :Yellow CrystalsMasse moléculaire :421.8399Tetrahydrozoline Related Compound C (1,2,3,4-Tetrahydronaphthalene-1-carboxylic acid)
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C11H12O2Couleur et forme :White SolidMasse moléculaire :176.08373Famciclovir Related Compound F (2-Amino-6-chloropurine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C5H4ClN5Couleur et forme :Light Yellow Off-White PowderMasse moléculaire :169.01552Entecavir Related Compound A (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C27H31N5O2SiCouleur et forme :White Light Yellow PowderMasse moléculaire :485.2247Roflumilast Related Compound B (N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C13H8Cl2F2N2O3Couleur et forme :White PowderMasse moléculaire :347.988Methylphenidate Hydrochloride Erythro Isomer Solution
CAS :Produit contrôléCompounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H19NO2·HClCouleur et forme :Clear LiquidMasse moléculaire :269.11826Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C11H15NOCouleur et forme :Off-White PowderMasse moléculaire :177.25 g/molRivaroxaban
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H18ClN3O5SCouleur et forme :White PowderMasse moléculaire :435.06557Gabapentin Related Compound A (2-Azaspiro[4.5]decan-3-one)
CAS :Lactams not elsewhere specified or includedFormule :C9H15NOCouleur et forme :Off-White PowderMasse moléculaire :153.11536Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C8H9ClN4O2Couleur et forme :White Off-White PowderMasse moléculaire :228.0414Tigecycline Related Compound B ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x))
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C23H28N4O7·HClCouleur et forme :Off-White PowderMasse moléculaire :472.1958Bendamustine Related Compound A (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H23N3O4HClCouleur et forme :White SolidMasse moléculaire :357.83Ropivacaine Related Compound B ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H26N2O·HCl·H2OCouleur et forme :White PowderMasse moléculaire :274.20451Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C32H43NO6Couleur et forme :Light Grey Blue PowderMasse moléculaire :537.30904Atenolol Related Compound G (2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}acetic acid)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C14H21NO4Couleur et forme :White SolidMasse moléculaire :267.14706Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C13H18Cl2N2·ClHCouleur et forme :White PowderMasse moléculaire :308.06138Triethylamine
CAS :Acyclic monoamines and their derivatives, nesoiFormule :C6H15NCouleur et forme :Clear Colorless LiquidMasse moléculaire :101.12045Lisinopril Related Compound A ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-α]pyrazin-2(1H)-yl}-4-phenylbutanoic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C21H29N3O4Couleur et forme :Yellow Off-White Crystalline PowderMasse moléculaire :387.21581Decitabine Related Compounds B and C Mixture (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H18Cl2N4O6andC22H18Cl2N4O6Couleur et forme :White PowderMasse moléculaire :504.06034Vecuronium Bromide Related Compound F (Piperidinium,1-[(2β,3α,5α,16β,17β)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H55BrN2O3Couleur et forme :White Off-White PowderMasse moléculaire :594.33961Meloxicam Related Compound B (5-Methylthiazol-2-amine)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C4H6N2SCouleur et forme :Light Yellow Light Brown Crystalline PowderMasse moléculaire :114.025175-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H5NO3Couleur et forme :White SolidMasse moléculaire :127.02694Gabapentin Related Compound E (Carboxymethylcyclohexanecarboxylic acid)
CAS :Cyclanic, cyclenic or cycloterpenic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFormule :C9H14O4Couleur et forme :Off-White White SolidMasse moléculaire :186.08921Baclofen Related Compound A (4-(4-Chlorophenyl)-2-pyrrolidinone)
CAS :Lactams, nesoiFormule :C10H10ClNOCouleur et forme :White CrystalsMasse moléculaire :195.04509Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS :Lactones, nesoiFormule :C27H40O6Couleur et forme :PowderMasse moléculaire :460.6Oxaliplatin Related Compound A (Oxalic acid dihydrate)
CAS :Oxalic acid, its salts and estersFormule :C2H2O4Couleur et forme :Colorless PowderMasse moléculaire :89.99531Trazodone Related Compound C (2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H22ClN5O·HClCouleur et forme :Off-White PowderMasse moléculaire :371.15129Losartan Related Compound E (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1- yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C44H43Cl2KN12OCouleur et forme :PowderMasse moléculaire :864.26969Bendamustine Related Compound H (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C32H41Cl3N6O4Couleur et forme :Off-White Yellow Orange SolidMasse moléculaire :678.22549Losartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C44H43Cl2KN12OCouleur et forme :PowderMasse moléculaire :864.26969Boc-Phe(4-NO2)-OH
CAS :Formule :C14H18N2O6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :310.30252-[(2E,4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile
CAS :Formule :C14H9Cl2N3S2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :354.2774Chlorotripyrrolidinophosphonium hexafluorophosphate
CAS :Formule :C12H24ClF6N3P2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :421.7300Leucine, N-[(1,1-dimethylethoxy)carbonyl]-
CAS :Formule :C11H21NO4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :231.2887Fmoc-Sar-OH
CAS :Formule :C18H17NO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :311.3319Ref: IN-DA003SPT
5g21,00€10g25,00€1kg267,00€25g25,00€50g47,00€100g63,00€10kgÀ demander500g192,00€100kgÀ demanderD-Arginin
CAS :Formule :C6H14N4O2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :174.2010Prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11α)-
CAS :Formule :C20H32F2O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :390.46191-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
CAS :Formule :C21H26ClN3OSDegré de pureté :97%Couleur et forme :SolidMasse moléculaire :403.96861-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
CAS :Formule :C15H10FNODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :239.24443α,12α-Dihydroxy-5β-cholanic acid
CAS :Formule :C24H40O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :392.57202-amino-3-phenylpropanoic acid
CAS :Formule :C9H11NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :165.18915-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-(chloromethyl)-8-oxo-7-[(phenylacetyl)amino]-,(4-methoxyphenyl)methyl ester, (6R,7R)-
CAS :Formule :C24H23ClN2O5SDegré de pureté :97%Couleur et forme :SolidMasse moléculaire :486.967817a-Acetoxy-6-methyl-16-methylene-4,6-pregnadiene-3,20-dione
CAS :Formule :C25H32O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :396.5192Silver, [4-amino-N-(2-pyrimidinyl-kN1)benzenesulfonamidato-kO]-
CAS :Formule :C10H9AgN4O2SDegré de pureté :97%Couleur et forme :SolidMasse moléculaire :357.13734H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-β-D-glucopyranosyl-5,7-dihydroxy-
CAS :Formule :C21H20O11Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :448.37692,4,6-Triisopropylbenzene-1-sulfonyl chloride
CAS :Formule :C15H23ClO2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.85993-Azido-7-hydroxycoumarin
CAS :Formule :C9H5N3O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :203.1543Ref: IN-DA0056YH
1gÀ demander5gÀ demander10gÀ demander25gÀ demander50gÀ demander25mg93,00€50mg114,00€100mg157,00€250mg212,00€500mg604,00€Benzene, 1,2,4-trimethoxy-5-(1E)-1-propen-1-yl-
CAS :Formule :C12H16O3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :208.25362H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydrochloride, hydrate (1:1:1)
CAS :Formule :C21H24Cl2N4O2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :467.4119Decamethonium Bromide
CAS :Formule :C16H38Br2N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :418.2943(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
CAS :Formule :C37H48N4O5Degré de pureté :%Couleur et forme :SolidMasse moléculaire :628.8008Ref: IN-DA003RD4
1g158,00€5gÀ demander100gÀ demander10mg30,00€25mg50,00€50mg50,00€100mg65,00€250mg99,00€4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[(2R)-aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-,[[[(2S,6R)-3,3-dimethyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]oxy]methylester,(2S,5R,6R)-,(4-methylbenzenesulfonate)(1:1)
CAS :Formule :C32H38N4O12S3Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :766.8587β-Alanine, N-(phenylmethyl)-, ethyl ester
CAS :Formule :C12H17NO2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :207.2689Levamisole HCl
CAS :Formule :C11H13ClN2SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :240.75233,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-,(2R,3R,4R,5S)-
CAS :Formule :C8H17NO5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :207.2243L-Valine, methyl ester, hydrochloride (1:1)
CAS :Formule :C6H14ClNO2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :167.6339Ref: IN-DA003QY9
5g20,00€10g20,00€25g26,00€100g27,00€10kg558,00€200g50,00€25kgÀ demander300g56,00€500g62,00€50kgÀ demander4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide hydrate
CAS :Formule :C27H31N5O7SDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :569.6293Dicarbonic acid, 1,3-diethyl ester
CAS :Formule :C6H10O5Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :162.14062-Pyrrolidinecarboxamide, (2R)-
CAS :Formule :C5H10N2ODegré de pureté :97%Couleur et forme :SolidMasse moléculaire :114.1457Brompheniramine hydrogen maleate
CAS :Formule :C20H23BrN2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :435.31161-Ethynyl-4-hexylbenzene
CAS :Formule :C14H18Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :186.2927Noscapine
CAS :Formule :C22H23NO7Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :413.4205Carbamic acid, N-[(1R)-2-hydroxy-1-phenylethyl]-, 1,1-dimethylethyl ester
CAS :Formule :C13H19NO3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :237.2949Ref: IN-DA0006LR
1g21,00€5g21,00€10g25,00€25g30,00€5kgÀ demander100g63,00€10kgÀ demander25kgÀ demander500g184,00€(2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid
CAS :Formule :C5H9NO3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :131.1299H-D-Lys-OH.HCl
CAS :Formule :C6H15ClN2O2Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :182.6485Benzoic acid, 2-(phenylamino)-
CAS :Formule :C13H11NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :213.2319Tos-Gly-OH
CAS :Formule :C9H11NO4SDegré de pureté :96%Couleur et forme :SolidMasse moléculaire :229.25297-Benzofuranol, 2,3-dihydro-2,2-dimethyl-
CAS :Formule :C10H12O2Degré de pureté :98%Couleur et forme :LiquidMasse moléculaire :164.2011Neostigmine Bromide
CAS :Formule :C12H19BrN2O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :303.1955Propanoic acid, 3-amino-2-hydroxy-, (2S)-
CAS :Formule :C3H7NO3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :105.09261-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one
CAS :Formule :C21H27NO3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :341.4440Cupric acetate,anhydrous
CAS :Formule :C4H6CuO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :181.6340Ref: IN-DA0034MY
10g20,00€25g20,00€50g24,00€5kg181,00€100g24,00€250g38,00€25kg556,00€500g49,00€50kgÀ demander100kgÀ demanderN-Tosyl-L-alanine
CAS :Formule :C10H13NO4SDegré de pureté :97%Couleur et forme :SolidMasse moléculaire :243.27951-Boc-3-Carbamoylpiperidine
CAS :Formule :C11H20N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :228.2881Mono-6-O-(p-toluenesulfonyl)-β-cyclodextrin
CAS :Formule :C49H76O37SDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :1289.1705N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-glutamic Acid
CAS :Formule :C20H19NO6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :369.3680Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxy-, hydrochloride (1:1)
CAS :Formule :C20H27ClN2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :394.89244H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)-
CAS :Formule :C6H6O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :142.10941,4-Diazabicyclo(2.2.2)octane
CAS :Formule :C6H12N2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :112.1729Ref: IN-DA00384D
1kg58,00€25gÀ demander50g20,00€5kg165,00€100g26,00€10kg235,00€250g28,00€25kg516,00€500g38,00€100kgÀ demanderBenzoic acid, 4-amino-2-hydroxy-, sodium salt (1:1)
CAS :Formule :C7H6NNaO3Degré de pureté :%Masse moléculaire :175.11722-Furanpropanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αS)-
CAS :Formule :C22H19NO5Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :377.39002-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide hydrochloride
CAS :Formule :C10H16ClN3O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :293.7041Butanoic acid, 4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-
CAS :Formule :C13H13N3O5S2Degré de pureté :%Couleur et forme :SolidMasse moléculaire :355.3894Boc-ε-Acp-OH
CAS :Formule :C11H21NO4Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :231.28872H-Benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-
CAS :Formule :C20H21F3N4ODegré de pureté :99%Couleur et forme :SolidMasse moléculaire :390.40214-Amino-N-(6-methoxy-4-pyrimidinyl)benzenesulfonamide
CAS :Formule :C11H12N4O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :280.30302,4-Heptadienamide,7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-
CAS :Formule :C17H22N2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :302.3682Benzaldehyde, 4-(difluoromethoxy)-3-hydroxy-
CAS :Formule :C8H6F2O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :188.1282Bromotris(dimethylamino)phosphonium hexafluorophosphate(V)
CAS :Formule :C6H18BrF6N3P2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :388.0692Sucralfate
CAS :<p>Sucralfate (Sucrose octasulfate–aluminum complex) is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active</p>Formule :C12H54Al16O75S8Degré de pureté :98%Couleur et forme :White Amorphous PowderMasse moléculaire :2086.75(9S)-6'-Methoxycinchonan-9-ol
CAS :Formule :C20H24N2O2Degré de pureté :85%Couleur et forme :SolidMasse moléculaire :324.416810H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (E)-2-butenedioate (1:1)
CAS :Formule :C23H23NO5SDegré de pureté :95%Couleur et forme :SolidMasse moléculaire :425.49744-Biphenylacetic acid
CAS :Formule :C14H12O2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :212.2439Tributylammonium pyrophosphate
CAS :Formule :C24H58N2O7P2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :548.67404-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
CAS :Formule :C29H31N7ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :493.6027Ref: IN-DA00350H
1g25,00€5g33,00€10g56,00€1kg506,00€25g61,00€5kgÀ demander100g164,00€10kgÀ demander500g687,00€Cytidine 5'-(trihydrogen diphosphate), P'-[2-(trimethylammonio)ethyl]ester, inner salt
CAS :Formule :C14H26N4O11P2Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :488.3240Cyclohexanecarboxamide,4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-
CAS :Formule :C29H41F2N5ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :513.6655Ref: IN-DA00I7ET
1gÀ demander5gÀ demander1mg54,00€5mg54,00€25mg129,00€50mg153,00€100mg172,00€250mg339,00€2-(Prop-2-yn-1-yloxy)isoindoline-1,3-dione
CAS :Formule :C11H7NO3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :201.1782
![Orphenadrine Related Compound C (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1479031.webp&w=3840&q=75)
![Nebivolol Related Compound D ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1457888.webp&w=3840&q=75)
![Clomipramine Related Compound F (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1140292.webp&w=3840&q=75)
![Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]be…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1444235.webp&w=3840&q=75)
![Telmisartan Related Compound A (1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole monohydrat…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1643420.webp&w=3840&q=75)
![Famotidine Related Compound B (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1269221.webp&w=3840&q=75)
![2-[(2E,4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003RDP.webp&w=3840&q=75)
![Leucine, N-[(1,1-dimethylethoxy)carbonyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00HSGE.webp&w=3840&q=75)
![5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-(chloromethyl)-8-oxo-7-[(phenylacetyl)amin…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00HAAG.webp&w=3840&q=75)
![Silver, [4-amino-N-(2-pyrimidinyl-kN1)benzenesulfonamidato-kO]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I4D8.webp&w=3840&q=75)
![2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-, hydr…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0019YR.webp&w=3840&q=75)
![(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003RD4.webp&w=3840&q=75)
![4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,6-[[(2R)-aminophenylacetyl]amino]-3,3-dimethyl-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0036J1.webp&w=3840&q=75)
![4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA001PAX.webp&w=3840&q=75)
![Carbamic acid, N-[(1R)-2-hydroxy-1-phenylethyl]-, 1,1-dimethylethyl ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0006LR.webp&w=3840&q=75)
![1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA019FSI.webp&w=3840&q=75)
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-glutamic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003SMF.webp&w=3840&q=75)
![Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxy-, hydrochloride …](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA000JPW.webp&w=3840&q=75)
![2-Furanpropanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αS)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA001R8K.webp&w=3840&q=75)
![2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA001LFZ.webp&w=3840&q=75)
![Butanoic acid, 4-oxo-4-[[4-[(2-thiazolylamino)sulfonyl]phenyl]amino]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA000BCQ.webp&w=3840&q=75)
![2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA001XOQ.webp&w=3840&q=75)
![2,4-Heptadienamide,7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-, (2E,4E,6R)-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA0035QF.webp&w=3840&q=75)
![10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (E)-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA003R69.webp&w=3840&q=75)
![4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benz…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00350H.webp&w=3840&q=75)
![Cytidine 5'-(trihydrogen diphosphate), P'-[2-(trimethylammonio)ethyl]ester, inner salt](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00IK5R.webp&w=3840&q=75)
